March 20, 2018
Hikma launches Ritonavir Tablets USP
Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
March 19, 2018
BD strips remaining stake in Vyaire Medical for $435 million
BD said Monday today it will divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners for $435…
March 19, 2018
Cidara Therapeutics might have once-weekly treatment option for patients with difficult-to-treat and deadly invasive Candida infections
The results reported by Cidara Therapeutics, for its lead antifungal candidate rezafungin acetate, which met all of its primary objectives,…
March 19, 2018
Boehringer Ingelheims’ snintedanib for treatment of a type of systemic sclerosis gets fast tracked by the FDA
Boehringer Ingelheim’s nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD), has been put to the fast…
March 19, 2018
Baxter broadens its surgical hemostat and sealand portfolio with Recothrom and Preveleak acquisition
Baxter International has completed the acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is…
March 19, 2018
Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer
Matinas BioPharma has appointed Jerome D. Jabbour, Co-founder and President of Matinas, as its Chief Executive Officer (“CEO”) and a…
March 16, 2018
J&J gets offer from Platinum Equity to buy LifeScan for $2.1 billion
Johnson & Johnson has received a binding offer from Platinum Equity, a private investment firm, to acquire its LifeScan business…
March 15, 2018
Amryt plans for series of agreements after an exclusive in-licence deal for a novel gene therapy platform, potentially exciting treatment for Epidermolysis bullosa
Joe Wiley, CEO of Amryt, said Amryt has an ambitious plans for the remainder of 2018 as it looks forward to…
March 15, 2018
Midatech names new CEO to take over in June
Midatech said its CEO, Dr Jim Phillips will step down at the end of May 2018 after five years, and he…
March 15, 2018
FDA fast tracks Destiny Pharma’s candidate for prevention of infections like MRSA
FDA has fast tracked Destiny Pharma’s lead clinical candidate exeporfinium chloride (XF-73) for the prevention of post-surgical staphylococcal infections such…